ASHCROFT SURGERY
803 STOCKPORT ROAD, LEVENSHULME, MANCHESTER
HF 4
The percentage of patients with a current diagnosis of heart failure due to LVD who are currently treated with an ACE inhibitor or Angiotensin Receptor Blocker, who are additionally treated with a beta-blocker licensed for heart failure, or recorded as intolerant to or having a contraindication to beta-blockers.
| Indicator | Year | Numerator | Denominator | Ratio | Centile |
|---|---|---|---|---|---|
| HF 4 | 2010 | 5 | 6 | 83.3% | |
| HF 4 | 2011 | 8 | 10 | 80.0% | |
| HF 4 | 2012 | 9 | 11 | 81.8% | |
| HF 4 | 2013 | 13 | 13 | 100.0% | |
| HF004 | 2014 | 20 | 21 | 95.2% | |
| HF004 | 2015 | 26 | 26 | 100.0% | |
| HF004 | 2016 | 37 | 39 | 94.9% | |
| HF004 | 2017 | 40 | 40 | 100.0% | |
| HF004 | 2018 | 39 | 43 | 90.7% | |
| HF004 | 2019 | 41 | 50 | 82.0% | |
| HF004 | 2020 | 43 | 50 | 86.0% | |
| HF006 | 2021 | 46 | 58 | 79.3% | |
| HF006 | 2022 | 50 | 53 | 94.3% | |
| HF006 | 2023 | 46 | 48 | 95.8% |
